Home / Tag Archives: migraine

Tag Archives: migraine

Amgen (AMGN) Announces FDA Approval for Migraine Treatment Aimovig

Enter StreetInsider Premium on Wall Street. Claim Your 2-Week Free Trial Here! Late Thursday, Amgen (NASDAQ: AMGN) announced that the FDA approved Aimovig for the preventative treatment of migraine in adults. Aimovig is a novel therapeutic approach that was developed as the first and only FDA-approved treatment for the prevention of migraine by blocking the receptor for cephalone gene-associated peptides …

Read More »

Amgens Aimovig won the first migraine nod of his class. Will the payers raise the $ 6,900 price?

Amgen and Novartis inaugurated a highly anticipated new class of migraine on Wednesday with FDA approval for Aimovig, an injectable drug with blockbuster hopes. But Aimovig still has some hurdles to overcome before he can achieve these high goals. Partners Need to Win Payers Who Have Already Warned How Expensive This New Med-type Targeting the Calcitonin Gene-Related Peptide Pathway You've …

Read More »

Express Scripts targets Amgen, Lilly migraine drugs in price development

LOS ANGELES (Reuters) – The largest US prescription manager tells drug manufacturers that the current pricing model is broken and Amgen Inc., Eli Lilly and Co. and other migraine drug manufacturers are trying to fix it. FILE PHOTO: An Amgen Sign is seen at the company's office in South San Francisco, California, USA, October 21, 2013. REUTERS / Robert Galbraith …

Read More »